标题
Targeting CDK9 for the Treatment of Glioblastoma
作者
关键词
-
出版物
Cancers
Volume 13, Issue 12, Pages 3039
出版商
MDPI AG
发表日期
2021-06-18
DOI
10.3390/cancers13123039
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The multi-kinase inhibitor TG02 induces apoptosis and blocks B-cell receptor signaling in chronic lymphocytic leukemia through dual mechanisms of action
- (2021) Rong Chen et al. Blood Cancer Journal
- Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas
- (2021) Jing Wu et al. CLINICAL CANCER RESEARCH
- Current FDA-Approved Therapies for High-Grade Malignant Gliomas
- (2021) Jacob P. Fisher et al. Biomedicines
- Interferon‑β sensitizes human glioblastoma cells to the cyclin‑dependent kinase inhibitor, TG02
- (2020) Birthe Lohmann et al. Oncology Letters
- Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib
- (2020) Christin Riess et al. Frontiers in Immunology
- Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update
- (2020) Tizhi Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting CDK9: A novel biomarker in�the�treatment of endometrial cancer
- (2020) Shasha He et al. ONCOLOGY REPORTS
- Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences
- (2020) C. Louwrens Braal et al. DRUGS
- Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02
- (2020) Caroline von Achenbach et al. Translational Oncology
- Harnessing Radiation Biology to Augment Immunotherapy for Glioblastoma
- (2019) Karishma R. Rajani et al. Frontiers in Oncology
- Challenges to curing primary brain tumours
- (2019) Kenneth Aldape et al. Nature Reviews Clinical Oncology
- Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
- (2019) Sobhani et al. Cells
- Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastoma
- (2019) Jian-Fang Ning et al. Nature Communications
- A Dual Inhibitor of Cdc7/Cdk9 Potently Suppresses T Cell Activation
- (2019) Elijah W. Chen et al. Frontiers in Immunology
- Targeting cyclin-dependent kinase 9 sensitizes medulloblastoma cells to chemotherapy
- (2019) Heyu Song et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CDK9 inhibitors reactivate p53 by downregulating iASPP
- (2019) Jiale Wu et al. CELLULAR SIGNALLING
- T-cell Dysfunction in Glioblastoma: Applying a New Framework
- (2018) Karolina I. Woroniecka et al. CLINICAL CANCER RESEARCH
- Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
- (2018) Dewan Md Sakib Hossain et al. JOURNAL OF CLINICAL INVESTIGATION
- Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent
- (2018) Steven T. Sizemore et al. MOLECULAR CANCER RESEARCH
- Immunotherapy in CNS cancers: the role of immune cell trafficking
- (2018) Nivedita M Ratnam et al. NEURO-ONCOLOGY
- Silencing LDHA inhibits proliferation, induces apoptosis and increases chemosensitivity to temozolomide in glioma cells
- (2018) Hui Di et al. Oncology Letters
- Human endogenous retroviruses and their implication for immunotherapeutics of cancer
- (2018) A S Attermann et al. ANNALS OF ONCOLOGY
- Abstract 2310: Targeting transcription-associated CDKs is an effective way to combat glioblastoma and medulloblastoma with minimal effect on primary neurons
- (2018) Isha Bhutada et al. CANCER RESEARCH
- Overcoming CDK4/6 inhibitor resistance in ER positive breast cancer.
- (2018) Neil Portman et al. ENDOCRINE-RELATED CANCER
- Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma
- (2018) Jennie W. Taylor et al. JOURNAL OF NEURO-ONCOLOGY
- Primary brain tumours in adults
- (2018) Sarah Lapointe et al. LANCET
- Structure of activated transcription complex Pol II–DSIF–PAF–SPT6
- (2018) Seychelle M. Vos et al. NATURE
- Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
- (2018) Hanghang Zhang et al. CELL
- Profound, durable and MGMT‐independent sensitivity of glioblastoma cells to cyclin‐dependent kinase inhibition
- (2018) Emilie Le Rhun et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting regulation of cyclin dependent kinase 9 as a novel therapeutic strategy in synovial sarcoma
- (2018) Xiaoyang Li et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
- (2018) Hangzhan Ma et al. EBioMedicine
- Transcription elongation factors represent in vivo cancer dependencies in glioblastoma
- (2017) Tyler E. Miller et al. NATURE
- EXTH-67. TG02, A BRAIN-PENETRANT MULTI-CDK INHIBITOR, POTENTLY SUPPRESSES MYC-DRIVEN GLIOBLASTOMA
- (2017) Jonathan Tsang et al. NEURO-ONCOLOGY
- CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
- (2017) Anna-Laura Kretz et al. TUMOR BIOLOGY
- Overview of CDK9 as a target in cancer research
- (2016) Fatima Morales et al. CELL CYCLE
- RBPJ maintains brain tumor–initiating cells through CDK9-mediated transcriptional elongation
- (2016) Qi Xie et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype
- (2016) Feimeng Zheng et al. Nature Communications
- BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
- (2016) Rikke D. Rasmussen et al. Nature Communications
- Inhibition of CDK9 as a therapeutic strategy for inflammatory arthritis
- (2016) Annelie Hellvard et al. Scientific Reports
- The impact of CDK9 on radiosensitivity, DNA damage repair and cell cycling of HNSCC cancer cells
- (2015) KATJA STORCH et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Getting up to speed with transcription elongation by RNA polymerase II
- (2015) Iris Jonkers et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Toward precision medicine in glioblastoma: the promise and the challenges
- (2015) Michael D. Prados et al. NEURO-ONCOLOGY
- The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
- (2015) Chiara Pastori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis
- (2015) Xiangrong Liu et al. TUMOR BIOLOGY
- HOTAIR is a therapeutic target in glioblastoma
- (2015) Xuan Zhou et al. Oncotarget
- Compensatory induction of MYC expression by sustained CDK9 inhibition via a BRD4-dependent mechanism
- (2015) Huasong Lu et al. eLife
- Phase I Study of RGB-286638, A Novel, Multitargeted Cyclin-Dependent Kinase Inhibitor in Patients with Solid Tumors
- (2014) D. A. J. van der Biessen et al. CLINICAL CANCER RESEARCH
- CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma
- (2014) Chun-Hao Huang et al. GENES & DEVELOPMENT
- Brd4 and JMJD6-Associated Anti-Pause Enhancers in Regulation of Transcriptional Pause Release
- (2013) Wen Liu et al. CELL
- The good, the bad and the ugly: Epigenetic mechanisms in glioblastoma
- (2012) Helena Carén et al. MOLECULAR ASPECTS OF MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A role for cdk9-cyclin k in maintaining genome integrity
- (2011) David S. Yu et al. CELL CYCLE
- Overcoming anoikis - pathways to anchorage-independent growth in cancer
- (2011) M. C. Guadamillas et al. JOURNAL OF CELL SCIENCE
- TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties
- (2011) K C Goh et al. LEUKEMIA
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation
- (2011) Weiwei Yang et al. NATURE
- Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme
- (2011) Amparo Wolf et al. NEUROBIOLOGY OF DISEASE
- 55K isoform of CDK9 associates with Ku70 and is involved in DNA repair
- (2010) Hongbing Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of the cyclin-dependent kinase 9-related pathway in mammalian gene expression and human diseases
- (2010) Gaetano Romano et al. CELL CYCLE
- Cyclin-dependent kinase 9–cyclin K functions in the replication stress response
- (2010) David S Yu et al. EMBO REPORTS
- A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours
- (2009) Edwina N. Scott et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Notch Promotes Radioresistance of Glioma Stem Cells
- (2009) Jialiang Wang et al. STEM CELLS
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now